1-4 of 4
Lucy DeCosta, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patient's Preference for Making Informed Treatment Decisions Confidently: Results from a Large Multiple Myeloma Patient Survey across 12 Countries in Europe and Israel

Alessandra Brescianini, MD, Renaud Desgraz, MD, Ananda Plate, MSc, Kathryn E. Morgan, MSc, Ana Vallejo, MSc, Sally Wetten, MSc, Lucy DeCosta, MSc, Florence Suzan, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23.
https://doi.org/10.1182/blood-2020-142532
Published: 2020
Journal Articles

Carfilzomib 56mg/m2 Twice-Weekly in Combination with Dexamethasone and Daratumumab (KdD) Versus Daratumumab in Combination with 8 Cycles of Bortezomib and Dexamethasone (DVd); A Matching-Adjusted Indirect Treatment Comparison

Katja Weisel, MD, Ajay Nooka, MDMPH, Evangelos Terpos, MDPhD, Andrew Spencer, Hartmut Goldschmidt, MD, Istvan Majer, PhD, Lucy DeCosta, MSc, Rohan Medhekar, PhD, Akeem Yusuf, PhD BPharm, Shaji K. Kumar, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-141995
Published: 2020
Journal Articles

Association between Patient Profile and Outcomes of Best Responders to Carfilzomib: A Post-Hoc Sub-Group Analysis of Aspire and Endeavor

Katja Weisel, MD, Maria-Victoria Mateos, MD PhD, Francesca Marianatal Gay, MD PhD, Michel Delforge, MD PhD, Gordon Cook, Lucy DeCosta, MSc, Renaud Desgraz, Zsolt Szabo, Philippe Moreau
Journal: Blood
Blood (2018) 132 (Supplement 1): 3299.
https://doi.org/10.1182/blood-2018-99-110957
Published: 2018
Journal Articles

Carfilzomib in Relapsed or Refractory Multiple Myeloma Patients with Early or Late Relapse Following Prior Therapy: A Subgroup Analysis of the Randomized Phase 3 Aspire and Endeavor Trials

Maria-Victoria Mateos, Hartmut Goldschmidt, MD, Jesus F San Miguel, MD PhD, Joseph Mikhael, MD, Lucy DeCosta, MSc, Lifen Zhou, Mihaela Obreja, Julie Blaedel, Zsolt Szabo, MD, Xavier Leleu, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3120.
https://doi.org/10.1182/blood.V130.Suppl_1.3120.3120
Published: 2017